임신 중 hydrolyzed wintergreen extract을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

hydrolyzed wintergreen extract은 임신 중 안전한가요?

Regulatory and scientific reviews treat methyl salicylate (the main constituent of wintergreen) as a substance of reproductive concern (SCCS/ECHA activity and ECHA/C&L references indicate a Repr.2/H361-level concern), so hazard is scored as suspected (h=2). Salicylates are metabolized to salicylate which is known to cross the placenta (mechanism demonstrated), so m=2. Dermal use of methyl salicylate produces measurable systemic exposure (used clinically in topical analgesics), so topical exposure is moderate (e=2). Sources: SCCS scientific advice on children’s exposure to methyl salicylate; ECHA/C&L and registration pages; CIR safety assessment of salicylates.

hydrolyzed wintergreen extract은 모유 수유 중 안전한가요?

Same intrinsic hazard (methyl salicylate → salicylate) so h=2. Mechanistic evidence of salicylate systemic distribution and transfer supports m=2. Dermal/topical products containing methyl salicylate can lead to measurable systemic levels; breastmilk transfer of salicylates is plausible based on known salicylate pharmacokinetics, so exposure for a breastfeeding parent is moderate (e=2). No infant-specific milk-transfer quantitative studies for methyl salicylate were identified in the searched sources.

hydrolyzed wintergreen extract은 아기 피부에 안전한가요?

Hazard and mechanism follow the parent compound (methyl salicylate) → h=2, m=2. Because infants (0–3 yr) have higher skin permeability and surface-area-to-weight, and regulators (SCCS) have issued specific tighter limits for methyl salicylate in products for 0–3 yr, exposure for baby skin from topical products is increased by +1 (adult e=2 → infant e=3). SCCS specifically reviewed children’s exposure and set much lower concentration limits for 0–3 year products, indicating elevated concern for this age group.

VeriMom은 hydrolyzed wintergreen extract을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 hydrolyzed wintergreen extract을 33/100 (높은 위험)로 평가합니다.

임신 중 hydrolyzed wintergreen extract 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.